The Detroit Cardiogenic Shock Initiative (CSI) is now the National Cardiogenic Shock Initiative. It was started by Dr. William O’Neill in 2016 as a collaboration between 5 different Detroit-area hospital systems with the goal of improving mortality in patients suffering from Cardiogenic Shock. Since then, the group has been using a common treatment protocol and collecting the data to track the results and measure their success. We are now expanding to 50 hospital sites nationwide with a goal of 500 patients.
Partnering hospital systems use a defined protocol for treatment of AMI patients in cardiogenic shock which includes quick placement of the lmpella heart pump, PCI, and right heart monitoring to rapidly reduce the use of inotropes. Quality data is collected on each patient. The initial pilot study has shown improvement in survival rates from 50% to 80% as presented at ACC.17.